Resumen Recientes investigaciones han relacionado la microbiota intestinal con la salud humana en múltiples aspectos. La evolución de los estilos de vida ha determinado un cambio en la composición de las bacterias intestinales, así como la implicación que la comunidad de estas ejerce sobre la salud. Actualmente, se conoce que la mayoría de las bacterias presentes en el sistema gastrointestinal pertenecen principalmente a los fila Firmicutes y Bacterioidetes, aunque también se encuentran otros grupos tales como proteobacterias y actinobacterias. A medida que se avanza en el tracto gastrointestinal predominan algunos géneros de bacterias. Los efectos de la microbiota pueden ser directos e indirectos, además, dependen de muchos factores tales como la edad de la persona, el grupo etario, la genética del individuo, la dieta y el estilo de vida. Durante los últimos años, la accesibilidad a tecnologías de secuenciación ha permitido tener un acercamiento más estrecho a la microbiota intestinal. Esto, sumado a herramientas bioinformáticas, ha permitido establecer relaciones microbiales entre la cantidad y estructura poblacional y las manifestaciones clínicas en el ser humano. Algunas de las afecciones estudiadas y que tienen relación con la microbiota intestinal son: la obesidad, la diabetes, el cáncer, las enfermedades relacionadas con el cerebro, las enfermedades cardiovasculares y las enfermedades gastrointestinales. De acuerdo con lo mencionado, se hizo una recopilación de información de carácter científico en cuanto a estudios relevantes que describen la relación microbiota-salud humana y casos donde se observa compromiso del organismo, al mismo tiempo que se describen opciones terapéuticas propuestas y un abordaje de perspectivas futuras.

Abstract Recent research has linked gut microbiota to human health in multiple ways. The evolution of lifestyles has determined a change in the composition of intestinal bacteria, as well as the implications that they exert on health. Currently, it is known that most of the bacteria present in the gastrointestinal sector belong mainly to the phylum Firmicutes and Bacterioidetes, although there are also other groups such as proteobacteria and actinobacteria. As it progresses through the gastrointestinal tract, some genera of bacteria and species predominate. The effects of the microbiota can be direct and indirect, and also depend on many factors such as the age of the person, the age group, the individual's genetics, diet, and lifestyle. In recent years, accessibility to sequencing technologies has allowed for a closer approach to the intestinal microbiota. This, added to bioinformatic tools has allowed establishing microbial relationships in terms of quantity and population structure with clinical manifestations in humans. Some of the pathologies studied that are related to intestinal microbiota are obesity, diabetes, cancer, brain-related diseases, cardiovascular diseases, and gastrointestinal diseases. A compilation of scientific information is made regarding relevant studies that describe the microbiota-human health relationship, cases where the organism is affected, as well as proposed therapeutic options and an approach to future perspectives.

RESUMEN El microbiota intestinal se encuentra constituida por más un millón de microorganismos entre los cuales las bacterias son de mayor prevalencia. Esta microbiota depende directamente de la localización exacta a lo largo del tubo digestivo, siendo la porción del colon la que alberga la mayor cantidad del microorganismo de la flora. El microbiota de la piel guarda relación directa con el microbiota del intestino por los diversos mecanismos existentes en la formación de la misma. El objetivo del presente estudio fue analizar el uso de probióticos y prebióticos en tratamiento de patología cutáneas y la relación entre la microbiota intestinal y enfermedades de la piel. Se realizó una revisión bibliográfica narrativa de la literatura científica de la relación del microbiota intestinal en patologías cutáneas. Se concluyó que el uso de probióticos y prebióticos juegan un papel importante en enfermedad cutáneas es especial de tipo inflamatoria.

RESUMO A microbiota intestinal é formada por mais de um milhão de microorganismos entre os quais as bactérias são as mais prevalentes. Esta microbiota depende diretamente da localização exata ao longo do trato gastrointestinal, sendo que a porção de cólon abriga a maior quantidade da flora de microorganismos. A microbiota da pele está diretamente relacionada à microbiota intestinal pelos diversos mecanismos envolvidos em sua formação. O objetivo deste estudo foi analisar o uso de probióticos e prebióticos no tratamento da patologia da pele e a relação entre a microbiota intestinal e as doenças de pele. Foi realizada uma revisão narrativa da literatura científica sobre a relação entre microbiota intestinal e patologias da pele. Concluiu-se que o uso de probióticos e prebióticos desempenha um papel importante nas doenças de pele, especialmente nas doenças inflamatórias da pele.

ABSTRACT The intestinal microbiota is constituted by more than one million microorganisms among which bacteria are the most prevalent. This microbiota is directly dependent on the exact location along the digestive tract, with the colon portion harboring the largest amount of the microorganism flora. The skin microbiota is directly related to the gut microbiota by the various mechanisms involved in its formation. The aim of the present study was to analyze the use of probiotics and prebiotics in the treatment of skin pathology and the relationship between the intestinal microbiota and skin diseases. A narrative bibliographic review of the scientific literature on the relationship between the intestinal microbiota and skin pathologies was carried out. It was concluded that the use of probiotics and prebiotics play an important role in skin diseases, especially inflammatory ones.

RESUMEN El microbiota intestinal se encuentra constituida por más un millón de microorganismos entre los cuales las bacterias son de mayor prevalencia. Esta microbiota depende directamente de la localización exacta a lo largo del tubo digestivo, siendo la porción del colon la que alberga la mayor cantidad del microorganismo de la flora. El microbiota de la piel guarda relación directa con el microbiota del intestino por los diversos mecanismos existentes en la formación de la misma. El objetivo del presente estudio fue analizar el uso de probióticos y prebióticos en tratamiento de patología cutáneas y la relación entre la microbiota intestinal y enfermedades de la piel. Se realizó una revisión bibliográfica narrativa de la literatura científica de la relación del microbiota intestinal en patologías cutáneas. Se concluyó que el uso de probióticos y prebióticos juegan un papel importante en enfermedad cutáneas es especial de tipo inflamatoria.

RESUMO A microbiota intestinal é formada por mais de um milhão de microorganismos entre os quais as bactérias são as mais prevalentes. Esta microbiota depende diretamente da localização exata ao longo do trato gastrointestinal, sendo que a porção de cólon abriga a maior quantidade da flora de microorganismos. A microbiota da pele está diretamente relacionada à microbiota intestinal pelos diversos mecanismos envolvidos em sua formação. O objetivo deste estudo foi analisar o uso de probióticos e prebióticos no tratamento da patologia da pele e a relação entre a microbiota intestinal e as doenças de pele. Foi realizada uma revisão narrativa da literatura científica sobre a relação entre microbiota intestinal e patologias da pele. Concluiu-se que o uso de probióticos e prebióticos desempenha um papel importante nas doenças de pele, especialmente nas doenças inflamatórias da pele.

ABSTRACT The intestinal microbiota is constituted by more than one million microorganisms among which bacteria are the most prevalent. This microbiota is directly dependent on the exact location along the digestive tract, with the colon portion harboring the largest amount of the microorganism flora. The skin microbiota is directly related to the gut microbiota by the various mechanisms involved in its formation. The aim of the present study was to analyze the use of probiotics and prebiotics in the treatment of skin pathology and the relationship between the intestinal microbiota and skin diseases. A narrative bibliographic review of the scientific literature on the relationship between the intestinal microbiota and skin pathologies was carried out. It was concluded that the use of probiotics and prebiotics play an important role in skin diseases, especially inflammatory ones.

RESUMEN La microbiota intestinal es la colección de microorganismos que habitan el sistema gastrointestinal de un ser humano. Estos microorganismos incluyen bacterias, virus, hongos y otros patógenos. La microbiota intestinal juega un papel importante en la salud general del cuerpo, ya que puede influir en el sistema inmune, la digestión y la absorción de nutrientes, y la producción de ciertas vitaminas. Objetivo. Determinar la relación entre la microbiota intestinal y enfermedades autoinmunes donde los microorganismos de la flora juegan un papel fundamental en la regulación de los diferentes mecanismos de defensa. Metodología. Se realizó una revisión sistemática, fue recopilada y clasificada la información usando el protocolo PRISMA, con la relación de la microbiota intestinal con enfermedades autoinmunes, cuyo algoritmo de búsqueda: (Relationship) and (intestinal) and (microbiota) and (autoimmune) and (diseases) entre los años 2017-2022. Finalmente, se encontraron 167 artículos. Conclusión. La microbiota intestinal puede tener una relación importante con el desarrollo y la progresión de algunas enfermedades autoinmunes, y el tratamiento con probióticos y prebióticos puede tener un efecto beneficioso en el curso de estas enfermedades, donde los microorganismos de la flora intestinal pueden desempeñar un papel crucial en la regulación del sistema inmune del cuerpo.

RESUMO A microbiota intestinal é o conjunto de microrganismos que habitam o sistema gastrointestinal de um ser humano. Esses microrganismos incluem bactérias, vírus, fungos e outros agentes patogênicos. A microbiota intestinal desempenha um papel importante na saúde geral do corpo, pois pode influenciar o sistema imunológico, a digestão e a absorção de nutrientes e a produção de determinadas vitaminas. Objetivo. Determinar a relação entre a microbiota intestinal e as doenças autoimunes, nas quais os microrganismos da flora desempenham um papel fundamental na regulação dos diferentes mecanismos de defesa. Metodologia. Foi realizada uma revisão sistemática, as informações foram coletadas e classificadas utilizando o protocolo PRISMA, com a relação da microbiota intestinal com doenças autoimunes, cujo algoritmo de busca: (Relationship) and (intestinal) and (microbiota) and (autoimmune) and (diseases) entre os anos de 2017-2022. Ao final, foram encontrados 167 artigos. Conclusões. A microbiota intestinal pode ter uma relação importante com o desenvolvimento e a progressão de algumas doenças autoimunes, e o tratamento com probióticos e prebióticos pode ter um efeito benéfico no curso dessas doenças, em que os microrganismos da flora intestinal podem desempenhar um papel crucial na regulação do sistema imunológico do corpo.

ABSTRACT The intestinal microbiota is the collection of microorganisms that inhabit the gastrointestinal system of a human being. These microorganisms include bacteria, viruses, fungi and other pathogens. The gut microbiota plays an important role in the overall health of the body, as it can influence the immune system, digestion and absorption of nutrients, and the production of certain vitamins. Objective. To determine the relationship between the intestinal microbiota and autoimmune diseases where the microorganisms of the flora play a fundamental role in the regulation of the different defense mechanisms. Methodology. A systematic review was performed, information was collected and classified using the PRISMA protocol, with the relationship of intestinal microbiota with autoimmune diseases, whose search algorithm: (Relationship) and (intestinal) and (microbiota) and (autoimmune) and (diseases) between the years 2017-2022. Finally, 167 articles were found. Conclusion. Gut microbiota may have an important relationship with the development and progression of some autoimmune diseases, and treatment with probiotics and prebiotics may have a beneficial effect on the course of these diseases, where gut flora microorganisms may play a crucial role in regulating the body's immune system.

RESUMO: O coco é uma fruta cultivada em mais de 80 países e devido ao seu excelente valor nutricional e biológico é uma importante cultura para a indústria alimentícia. Assim, desenvolver novos produtos à base de coco é atrativo para explorar os benefícios proporcionados por microrganismos e melhorar a composição nutricional e bioativa de produtos de coco, como na preparação de bebidas fermentadas. Este estudo desenvolveu e caracterizou uma bebida à base de coco seco com o prebiótico frutooligossacarídeo, fermentada pelo probiótico Lactobacillus casei. A bebida foi formulada, filtrada, fermentada, maturada e armazenada sob refrigeração (4 °C) por 28 dias; além de avaliada em relação às suas características físicas, químicas, antioxidantes e microbiológicas. Quando comparada à amostra padrão não-fermentada ao longo do armazenamento, a bebida fermentada apresentou variações significativas (P < 0.05) para cor instrumental, acidez e pH, enquanto as alterações para sólidos solúveis e índice de estabilidade foram observadas a partir do 7° dia de armazenamento. Em relação à composição química, todos os parâmetros variaram significativamente após o processo fermentativo. O teor de compostos fenólicos totais e capacidade antioxidante aumentaram significativamente após a fermentação. Reduções significativas foram observadas (P < 0,05) na viabilidade do Lactobacillus casei após a exposição às condições do trato gastrointestinal, com as seguintes contagens (em UFC mL-1) após 0 e 28 dias de armazenamento: - inicial: 9,23 ± 0.04 e 9,05 ± 0,12; após a fase gástrica: 6,21 ± 0,09 e 5,90 ± 0,01; e após a fase intestinal: 4,59 ± 0,33 e 4,75 ± 0,23, respectivamente.

ABSTRACT: Coconut is a fruit grown in more than 80 countries owing to its outstanding nutritional and biological value and it is an important crop for the food industry” por “Coconut is a fruit grown in more than 80 countries and owing to its outstanding nutritional and biological value and it is an important crop for the food industry. Thus, developing new coconut-based products is attractive to explore the benefits provided by microorganisms and improve the nutritional and bioactive composition of coconut products, such as by preparing fermented beverages. This study developed and characterize a drink based on dry coconut with the prebiotic fructooligosaccharide fermented by the probiotic Lactobacillus casei. The drink was formulated, filtered, fermented, matured, and stored under refrigeration (4 °C) for 28 days; it was evaluated for its physical, chemical, antioxidant, and microbiological characteristics. Compared to the standard non-fermented sample during storage, the fermented drink showed significant variations (P < 0.05) in instrumental color, acidity, and pH, while changes in soluble solids and stability index were observed after 7 days of storage. Regarding the chemical composition, all parameters varied significantly after fermentation. The total phenolic compound content and antioxidant capacity increased significantly after fermentation. Significant reductions were observed (P < 0.05) in the viability of Lactobacillus casei after exposure to gastrointestinal tract conditions, with the following counts (in log CFU mL-1) after 0 and 28 days of storage: - initial: 9.23 ± 0.04 and 9.05 ± 0.12; after the gastric phase: 6.21 ± 0.09 and 5.90 ± 0.01; and after the intestinal phase: 4.59 ± 0.33 and 4.75 ± 0.23, respectively.

ABSTRACT: There is a renewed interest in products based on phytocompounds, prebiotics and probiotics applied to different hosts to exert effects of immunomodulation, anti-inflammation and analgesia. The microbiome of the bovine reproductive tract can become unbalanced for many reasons, favoring the entry and proliferation of pathogenic microorganisms, currently treated with antibiotics that exert adverse effects and generate antimicrobial resistance. To deal with this situation, “phytobiotic” formulas are proposed that combine phytocompounds and probiotics. This work aims to study the effect of plant extracts, prebiotics and vitamins on the growth of native beneficial lactic acid bacteria (BLAB), to be further potentially applied in the design of phytobiotic formulas. Nine beneficial strains isolated from different bovine ecosystems were evaluated against nine phytocompounds, two prebiotics and five vitamins. Affinity was assayed using the diffusion technique on agar plates, and the effect of the phytocompounds on the growth of lactic acid bacteria by microplates. The growth of all the strains was affected by some plant extracts, showing a stimulating or inhibitory effect. Diffusion-agar plates show that only vitamin A affected the viability of Lactobacillus johnsonii CRL1702 at concentrations higher than 7.5 mg/ml. When studying the growth kinetics of the strains with the phytocompounds, the results show that the effect was different in each of one the associated strains + plant extracts, indicating a strain-specific effect of plant extracts on each BLAB strain. Lapacho and Malva stimulate the growth of most microorganisms, then were selected to be combined with BLAB to design a phytobiotic formula with potential therapeutic activity to treat bovine reproductive infections. Plant extracts at the evaluated concentrations did not inhibit the growth of most of the pathogens responsible for endometritis. On the other hand, the highest concentrations of phenolic compounds were detected in Echinacea, Lapacho and Llantén; and the best percentages of antioxidant activity were evidenced in Garlic, Blueberry and Chamomile (<60%).

Piglets experience stresses that impact intestinal homeostasis and result in a high incidence of diarrhoea and reduced growth performance during weaning. Recent studies have indicated that gastrointestinal tract microbiota can be nutritionally regulated in ways that can benefit and promote gut health in weaning piglets. In this review, we discuss different components of nutrition and their effects on microbial populations, diversity, and activity and, in turn, how these altered microbial structures and activities affect gut health in weaning piglets. In addition, we discuss some of the inner mechanisms through which microbiota regulate and exert their effects on gut health, focusing particularly on adaptive and innate immunity, inflammatory responses and intestinal barrier integrity. Most of the mechanisms involve the TLR and NF-kB signalling pathways, and miRNA regulation. An understanding of the effects of nutritional regulation of microbiota on gut health and its underlying mechanisms can be applied in developing nutritional regimens that promote beneficial microbial structures for gut health.

Obesity has a multifactorial etiological condition that involves more than half of the Brazilian population. More recently, the intestinal microbiota was considered a factor that contributes to this condition. The aims of this study were to review the intestinal microbiota influence in the obesity and in the inflammatory response, and to analyze the effects of using prebiotic and probiotic medications. A systematic review was firstly done. More than 27,000 articles were found, but only 16 contained the proper criteria. In conclusion, the microbiota imbalance seems to increase the obesity development and its inflammatory aspects. Both the use of pre and probiotics are good options in the obesity treatment, though the first ones seem to enhance bettere quality of life.

A obesidade tem causa multifatorial que atinge atualmente mais da metade da população brasileira. Mais recentemente, a microbiota intestinal foi considerada um fator que contribui para essa condição. Os objetivos deste estudo foram revisar a influência da microbiota intestinal na obesidade e no processo inflamatório, e analisar os efeitos da utilização dos pré e probióticos. Foi realizada revisão sistemática sobre o assunto. Dos mais de 27.000 artigos, apenas 16 respeitaram os critérios de inclusão. Em conclusão, o desequilíbrio da microbiota aparece como fator favorável ao desenvolvimento da obesidade e do quadro inflamatório decorrente dela. Tanto o uso de prebióticos quanto probióticos são recursos válidos no tratamento da obesidade, porém os primeiros parecem proporcionar melhor qualidade de vida.

Resumen Esta revisión tuvo como objetivo exponer las relaciones entre los aditivos en la dieta de los rumiantes y las consecuencias causadas en su nutrición. Los aditivos alimentarios se utilizan en la nutrición de los rumiantes para mejorar las características productivas y/o la calidad de los productos. Hay diversas categorías de aditivos disponibles para la nutrición de rumiantes, con énfasis en antibióticos, prebióticos, probióticos, extractos de plantas y enzimas exógenas. Los antibióticos, los aceites esenciales y el quitosano actúan seleccionando bacterias sensibles y consecuentemente modulan el patrón de fermentación ruminal. Los prebióticos favorecen la microbiota, proporcionando una mayor digestión y producción de ácidos grasos volátiles. Los probióticos son microorganismos que mejoran el ambiente ruminal, lo que resulta en una mayor digestión y producción de ácidos grasos volátiles. Las enzimas exógenas actúan sinérgicamente con las enzimas secretadas por los microorganismos ruminales, además de favorecer la adhesión microbiana y colonización de las partículas, ayudan en la degradación del alimento. Los taninos, ya sea alterando el estándar de fermentación y/o modificando la microbiota ruminal, todos los aditivos son efectivos para mejorar el rendimiento animal. Sin embargo, los efectos de los aditivos sobre los productos están relacionados con la calidad de la dieta.

Abstract This review illustrates the relationships between additives in the diets of ruminants and the consequence for ruminant nutrition. Feed additives are used to improve animal perfor mance and/or the quality of the products. There are several categories of additives available for ruminant nutrition, with emphasis on antibiotics, prebiotics, probiotics, plant extracts, and exogenous enzymes. Antibiotics, essential oils, and chitosan act by selecting sensitive bacteria, consequently modulating the ruminal fermentation pattern. Prebiotics favor microbial growth, providing greater digestion and the production of volatile fatty acids. Probiotics are living microorganisms that improve the ruminal environment, promoting microbial growth and resulting in increased digestion and the production of volatile fatty acids. Exogenous enzymes act synergistically with the enzymes secreted by the ruminal microorganisms, besides favoring microbial adhesion and colonization and facilitating feed degradation. Tannins, whether altering the fermentation standard and/or modifying the ruminal microbiota population, are effective in improving animal performance. However, the effects of additives on the quality of the products are linked to diet quality.

Abstract Background: gastrointestinal disorders (GIDs) are common comorbidities in patients with autism spectrum disorders (ASD); treatments with gluten- and casein-free (LGLC) diets or prebiotic/probiotic supplements may reduce the severity of GIDs. Objective: to integrate and discuss the evidence on the effectiveness of LGLC diet therapies and prebiotic/probiotic supplements on GIDs in patients with ASD. Methodology: the guidelines for the publication of systematic reviews and meta-analyses (PRISMA) were used. Participant characteristics, dietary interventions, prebiotic/prebiotic supplementation, effects of interventions on GIDs, risk of bias, and safety of treatments were analyzed. Results: fifteen investigations were analyzed; the prevalence of GIDs among patients with ASD was high (58 %; range, 27-83 %). In more than 20 % of the patients managed with LGLC diets or supplements GID severity decreased (mainly constipation, diarrhea, and abdominal pain). Increases in the counts of beneficial bacteria and a decrease in the proportion of pathogenic bacteria were reported after supplement use. However, all these investigations had significant methodological biases. Conclusions: although reductions in the frequency and severity of some GIDs have been found, the effectiveness of these treatments has not been proven yet. Given the methodological differences in the investigations, the design of rigorous studies to evaluate the therapeutic effects of these treatments on gastrointestinal health in patients with ASD is warranted.

Resumen Antecedentes: los trastornos gastrointestinales (TGI) son comorbilidades comunes en los pacientes con trastornos del espectro autista (TEA); los tratamientos con dietas libres de gluten y caseína (LGLC) o suplementos de prebióticos/probióticos podrían reducir la severidad de los TGI. Objetivo: integrar y discutir la evidencia sobre la efectividad de las terapias con dietas LGLC y suplementos de prebióticos/probióticos sobre los TGI en pacientes con TEA. Metodología: se utilizaron las guías para la publicación de revisiones sistemáticas y metaanálisis (PRISMA). Se analizaron las características de los participantes, las intervenciones dietéticas, la administración de suplementos de prebióticos/prebióticos, los efectos de las intervenciones sobre los TGI, el riesgo de sesgo de los estudios y la seguridad de los tratamientos. Resultados: se analizaron quince investigaciones; la prevalencia de los TGI entre los pacientes con TEA fue alta (58 %; rango, 27-83 %). En más del 20 % de los pacientes intervenidos con dietas LGLC o suplementos disminuyó la severidad de los TGI (principalmente estreñimiento, diarrea y dolor abdominal). Se reportaron aumentos en los conteos de bacterias benéficas y una disminución de la proporción de bacterias patógenas tras el uso de los suplementos. Sin embargo, todas estas investigaciones presentaron sesgos metodológicos importantes. Conclusiones: aunque se han encontrado reducciones en la frecuencia y severidad de algunos TGI, la efectividad de estos tratamientos aún no se ha comprobado. Dadas las diferencias metodológicas de las investigaciones, se justifica el diseño de estudios rigurosos para evaluar los efectos terapéuticos de estos tratamientos sobre la salud gastrointestinal en pacientes con TEA.

RESUMO Contexto A suplementação com probióticos, prebióticos e simbióticos mostrou efeitos positivos sobre marcadores clínicos e fatores de risco para doença hepática gordurosa não alcoólica (DHGNA). Objetivo Avaliar o efeito da suplementação com probióticos, prebióticos ou simbióticos na microbiota intestinal em pacientes com DHGNA. Métodos Dois pesquisadores realizaram buscas independentes de artigos nas bases de dados Medline, via PubMed, Web of Science, Embase, Scopus, Lilacs, Biblioteca Central Cochrane, Clinical Trials.gov e na plataforma Ovid para busca de literatura cinza. Os títulos e resumos foram lidos para excluir artigos irrelevantes. Em seguida, os artigos selecionados foram lidos na íntegra e avaliados de acordo com os critérios de elegibilidade. O risco de viés foi avaliado de acordo com a Cochrane. Resultados Um total de 3.423 artigos foram identificado por meio de busca nas bases de dados eletrônicas; 1.560 deles eram duplicados e foram excluídos; 1.825 artigos foram excluídos após a leitura do título e do resumo. Um total de 39 artigos foram selecionado para leitura, porém apenas quatro artigos atenderam aos critérios de elegibilidade para inclusão nesta revisão sistemática. Três dos estudos incluídos que utilizaram suplementação de prebióticos ou simbióticos mostraram que após a intervenção ocorreram mudanças no padrão da microbiota intestinal. Apenas em um estudo tais mudanças não foram observadas. Um elevado risco de viés foi observado na maioria das avaliações. Conclusão Embora haja uma possível alteração na microbiota intestinal de indivíduos com DHGNA após a suplementação com simbióticos ou prebióticos, uma indicação clínica como parte do tratamento da DHGNA ainda não é possível.

ABSTRACT Background Supplementation with probiotics, prebiotics and symbiotics has shown positive effects on clinical markers and risk factors for non-alcoholic fatty liver disease (NAFLD). Objective To evaluate the effect of supplementation with probiotic, prebiotic or symbiotic on intestinal microbiota in NAFLD patients. Methods Two investigators conducted independently search for articles in the Medline databases, via PubMed, Web of Science, Embase, Scopus, Lilacs, Central Cochrane Library, Clinical Trials.gov and on the Ovid platform for the gray literature search. Results A total of 3,423 papers were identified by searching the electronic databases; 1,560 of them were duplicate and they were excluded; 1,825 articles were excluded after reading the title and abstract. A total of 39 articles were select to reading, however only four articles met the eligibility criteria to include in this systematic review. Three of the included studies that used prebiotic or symbiotic supplementation showed that after the intervention there were changes in the intestinal microbiota pattern. Only in one study such changes were not observed. A high risk of bias was observed in most assessments. Conclusion Although there is a possible change in the gut microbiota of individuals with NAFLD after supplementation with symbiotics or prebiotics, a clinical indication as part of NAFLD treatment is not yet possible.

ABSTRACT Introduction: Helicobacter pylori infection has a wide worldwide distribution and is related to benign and malignant gastrointestinal diseases. Although there is no ideal scheme to eradicate the bacteria, the use of probiotics and prebiotics can serve as adjunctive therapy. Objective: To describe the clinical, endoscopic, histopathological manifestations and the eradication of Helicobacter pylori infection in patients treated with triple therapy and symbiotic fermented milk. Method: A descriptive, cross-sectional study was carried out from January 2017 to May 2019. 30 patients with Helicobacter pylori infection (diagnosed by histopathological study and urease test) were included. The variables included were: age, sex, clinical manifestations, endoscopic and histopathological diagnosis, and eradication of the bacteria. Descriptive statistics (percentage and measures of central tendency) were used to analyze the results. Results: There were 71 % female patients. The mean age was 48,6 ± 16,3 years; minimum age of 18 and maximum of 74 years. Dyspepsia was present in 46,6 % of patients and epigastric pain in 33,3 %. Erythematous antral, antral erythematous erythematonodular and erythematonodular gastritis occurred in 23,3% each. Moderate atrophic chronic gastritis was found in 40 % of individuals. Helicobacter pylori was eradicated in 96,7 % of patients. Conclusions: Female sex and the fourth decade of life predominated. Dyspepsia and moderate atrophic chronic gastritis are the most frequent symptom and histopathological diagnosis, respectively. Erythematous antral, antral erythematous, and erythematonodular gastritis represent the most common endoscopic diagnoses. The eradication rate of Helicobacter pylori was high.

RESUMEN Introducción: Helicobacter pylori se relaciona con enfermedades benignas y malignas gastrointestinales. No se dispone de un esquema ideal para su erradicación, pero el uso de probióticos y prebióticos puede servir como terapia adyuvante. Objetivo: Describir las manifestaciones clínicas, endoscópicas, histopatológicas y la erradicación de la infección por Helicobacter pylori en los pacientes tratados con triple terapia y leche fermentada simbiótica. Métodos: Se realizó un estudio descriptivo, entre enero de 2017 y mayo de 2019, en 30 pacientes con Helicobacter pylori (diagnosticado mediante estudio histopatológico y prueba de ureasa). Las variables incluidas fueron: edad, sexo, manifestaciones clínicas, diagnóstico endoscópico e histopatológico y erradicación de la bacteria. Para el análisis de los resultados se emplearon estadísticas descriptivas (porcentaje y medidas de tendencia central). Resultados: Hubo 71 % de pacientes femeninos. La edad media fue de 48,6 ± 16,3 años (mínima 18 y máxima de 74 años). La dispepsia estuvo presente en 46,6 % pacientes. La gastritis eritematosa antral, antral eritematoerosiva y eritemato nodular se presentaron en 23,3 % cada una. La gastritis crónica atrófica moderada estuvo presente en el 40 % de los individuos. En 96,7 % enfermos se erradicó la bacteria. Conclusiones: La dispepsia y la gastritis crónica atrófica moderada representan el síntoma y el diagnóstico histopatológico más frecuente, respectivamente. La gastritis eritematosa antral, antral eritematoerosiva y eritematonodular constituyen los diagnósticos endoscópicos más comunes. La tasa de erradicación de H. pylori es elevada.

Objective: To evaluate the use of probiotics and prebiotics supplementation in autistic children. Data source: Articles were identified in the PubMed and SciELO databases. In order to locate the studies, descriptors in English obtained from the Health Sciences Descriptors (DeCS), were used: Prebiotics. Probiotics. Autism Spectrum Disorder. Gut microbiota. Bifidobacterium. The search was limited to articles in Portuguese and English and comprised the years of publication between 2015-2021. Data synthesis: A total of 6 clinical trials conducted on children with autism have been systematically reviewed. Regarding the types of supplements used, there were 3 studies that used probiotics, 2 that used prebiotics and probiotics and 1 that made only the use of prebiotics. Despite the scarce amount of studies, they have had remarkable results in relation to the supplementation of probiotics and prebiotics in children with ASD. In some studies, it was possible to observe an improvement in the severity of autism and improvements in relation to antisocial behavior, while in others, there was an increase in beneficial bacteria and a decrease in pathogens in the gastrointestinal tract, leading to an improvement in recurrent gastrointestinal symptoms. Conclusions: It is noticeable that the use of prebiotics and probiotics can promote several benefits for people with autism, however studies with a larger number of individuals are necessary and there are standards regarding the intervention regimes.

Objetivo: Avaliar o uso da suplementação de probióticos e prebióticos em crianças autistas. Fonte de dados: Foram identificados artigos nas bases de dados PubMed e SciELO. Para a localização dos estudos foram utilizados descritores em inglês cadastrados no Descritores em Ciências da Saúde (DeCS): Prebiotics. Probiotics. Autism Spectrum Disorder. Gut microbiota. Bifidobacterium. A busca limitou-se a artigos em inglês e compreendeu os anos de publicação entre 2015-2021. Síntese de dados: Um total de 6 ensaios clínicos realizados em crianças com autismo foram revisados sistematicamente. Com relação aos tipos de suplementações utilizadas foram 3 estudos que utilizaram probióticos, 2 que utilizaram prebióticos e probióticos e 1 que fez apenas o uso de prebióticos.  Apesar da quantidade escassa de estudos, os mesmos tiveram resultados notáveis com relação à suplementação de probióticos e prebióticos em crianças com Transtorno do Espectro Autista. Em alguns estudos foi possível observar a melhora na gravidade do autismo e melhorias com relação ao comportamento antissocial, já em outros houve o aumento de bactérias benéficas e diminuição das patogênicas no trato gastrintestinal levando a melhora de sintomas gastrointestinais recorrentes. Conclusões: É perceptível que o uso de prébióticos e probióticos pode promover diversos benefícios para os portadores de autismo, porém são necessários estudos com um número maior de indivíduos e havendo padrões quanto aos regimes de intervenção.

Abstract In this study, synbiotic kefir types were produced by the addition of probiotic bacteria and prebiotics to cow and goat milk. Commercial DVS kefir cultures, Lactobacillus acidophilus LA-5, Bifidobacterium bifidum BB-11 as probiotic cultures and inulin as prebiotic for the production of the kefir samples. The effect of the different probiotics and prebiotic on some characteristics of kefir made from cow and goat milk was investigated. Titratable acidity, tyrosine content, volatile components and sensory properties of samples were examined on the 1st, 7th, 14th and 21st day of storage. According to the results, titratable acidity and tyrosine amount in kefir increased during the storage period. There was a gradual increase in the acetaldehyde value of kefir made from cow milk during the storage period, whereas there were no regular changes obtained in the kefir produced from goat milk. However, the diacetyl content varied in all the synbiotic products during storage. The total acceptability results showed that the synbiotic kefir made from cow milk was more preferred to the one made from goat milk.

Abstract The importance of functional foods added with probiotics and prebiotics is directly related with the promotion of the health benefits of human. In this study the survival of the probiotic Lactobacillus rhamnosus GG in a semi-ripened cheese added with agave juice, was determined. Cheese ripening was carried out at 14 °C for 35 days. The pH changes were measured and the hydrolysis of the protein was evaluated through the analysis of free amino groups by the trinitrobenzenesulfonic acid (TNBS) method and SDS-PAGE polyacrylamide gel electrophoresis. At the end of the study, in the symbiotic cheese, the viability of the probotic was increased in two logarithmic cycles (from 6.73 to 8.72 log CFU). A more active proteolytic process was observed with the addition of agave juice, due to the high production of low molecular weight peptides and the concentration of free amino groups (8.63 mg/L). The pH did not have a significant difference between the control and the cheese studied. With the obtained results, it is seen that agave juice is an ingredient that can be added to semi ripening cheeses with the objective of improving the survival capacity of probiotic microorganisms, which are used as starters.